P2Y12 Inhibitors in STEMI Patients - One Size Does Not Fit All

Cardiovasc Drugs Ther. 2024 Feb;38(1):5-7. doi: 10.1007/s10557-023-07497-2. Epub 2023 Aug 2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clopidogrel
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride
  • Purinergic P2Y Receptor Antagonists / adverse effects
  • ST Elevation Myocardial Infarction* / diagnosis
  • ST Elevation Myocardial Infarction* / drug therapy
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Purinergic P2Y Receptor Antagonists
  • Prasugrel Hydrochloride